CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in CalciMedica, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- 0 vs. Q2 2022
- Shares held
- 10.8M
- +84.2K (+0.8%) vs. Q2 2022
- Total value
- $10.2M
- −$1.53M (−13.0%) vs. Q2 2022
- New holders
- 3
- 6 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 5,281,713 | $4.97M | 0.10% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,163,347 | $3.92M | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 419,744 | $394.0K | 0.00% | −33,940−7.5% | Reduced |
| First Manhattan Co | 292,003 | $274.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 200,492 | $189.0K | 0.00% | +148,392+284.8% | Added |
| Bank of New York Mellon Corp | 100,981 | $95.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 66,393 | $62.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 64,000 | $60.0K | 0.00% | −50,000−43.9% | Reduced |
| Susquehanna International Group, LLP | 63,241 | $59.0K | 0.00% | +52,012+463.2% | Added |
| Johnson & Johnson | 49,547 | $47.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 35,073 | $33.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 19,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 18,333 | $17.0K | 0.00% | +1,233+7.2% | Added |
| Northern Trust Corp | 16,104 | $15.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 12,011 | $11.0K | 0.00% | +3,001+33.3% | Added |
| Jane Street Group, LLC | 11,455 | $11.0K | 0.00% | +11,455 | New |
| The PNC Financial Services Group, Inc. | 8,612 | $8.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 2,379 | $2.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 642 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 114 | $107 | 0.00% | +114 | New |
| UBS Group AG | 209 | $0 | 0.00% | −15,785−98.7% | Reduced |
| Wells Fargo & Company | 104 | $0 | 0.00% | +15+16.9% | Added |
| Simplex Trading, LLC | 966 | $0 | 0.00% | +750+347.2% | Added |
| Cutler Group LP | 200 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 7 | $0 | 0.00% | +7 | New |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −17,218−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |